Trending Breaking New|Politics Sports Crypto Finance Geopolitics Earnings Tech Pop Culture World Economy Climate & Science Elections Mentions

Crl Predictions & Odds· 146 markets

All Science Finance Earnings Tech Drug Equities CRL

Will Charles River Laboratories International (CRL) beat quarterly earnings?

Earnings·Equities

Will Charles River Laboratories International (CRL) beat quarterly earnings?

$8k Vol.

$0 Liq.

Ended

Yes

Will Charles River Laboratories (CRL) beat quarterly earnings?

Earnings·Hide From New

Will Charles River Laboratories (CRL) beat quarterly earnings?

$15k Vol.

$0 Liq.

Ended

Yes

FDA approves Dordaviprone?

FDA approves Dordaviprone?

$14k Vol.

$0 Liq.

12

Ended

Yes

FDA approves UX111?

FDA approves UX111?

$41k Vol.

$0 Liq.

12

Ended

No

FDA approves EYLEA HD?

FDA approves EYLEA HD?

$6k Vol.

$0 Liq.

12

Ended

No

FDA approves Donidalorsen?

FDA approves Donidalorsen?

$4k Vol.

$0 Liq.

12

Ended

Yes

FDA approves FILSPARI REMS modification?

FDA approves FILSPARI REMS modification?

$1k Vol.

$0 Liq.

12

Ended

Yes

FDA approves Leqembi auto-injection for early Alzheimer’s?

FDA approves Leqembi auto-injection for early Alzheimer’s?

$2k Vol.

$0 Liq.

12

Ended

Yes

FDA approves Telix Pharmaceuticals’ TLX250-CDx for kidney cancer imaging?

FDA approves Telix Pharmaceuticals’ TLX250-CDx for kidney cancer imaging?

$3k Vol.

$0 Liq.

12

Ended

No

FDA approves Precigen’s PRGN-2012 for recurrent respiratory papillomatosis?

FDA approves Precigen’s PRGN-2012 for recurrent respiratory papillomatosis?

$15k Vol.

$0 Liq.

12

Ended

Yes

FDA approves Outlook Therapeutics’ ONS-5010 for wet AMD?

FDA approves Outlook Therapeutics’ ONS-5010 for wet AMD?

$4k Vol.

$0 Liq.

4

Ended

No

FDA approves Sanofi’s Rilzabrutinib for immune thrombocytopenia?

FDA approves Sanofi’s Rilzabrutinib for immune thrombocytopenia?

$3k Vol.

$0 Liq.

12

Ended

Yes

FDA approves Capricor Therapeutics’ Deramiocel for Duchenne muscular dystrophy by August 31?

FDA approves Capricor Therapeutics’ Deramiocel for Duchenne muscular dystrophy by August 31?

$11k Vol.

$0 Liq.

12

Ended

No

FDA approves PTC Therapeutics’ Vatiquinone for Friedreich’s ataxia?

FDA approves PTC Therapeutics’ Vatiquinone for Friedreich’s ataxia?

$2k Vol.

$0 Liq.

12

Ended

No

FDA approves Tonix Pharmaceuticals’ TNX-102 SL for fibromyalgia?

FDA approves Tonix Pharmaceuticals’ TNX-102 SL for fibromyalgia?

$916 Vol.

$0 Liq.

12

Ended

Yes

FDA approves Insmed’s Brensocatib for bronchiectasis?

FDA approves Insmed’s Brensocatib for bronchiectasis?

$2k Vol.

$0 Liq.

12

Ended

Yes

FDA approves PharmaTher Holdings’ Ketamine?

FDA approves PharmaTher Holdings’ Ketamine?

$7k Vol.

$0 Liq.

12

Ended

Yes

FDA approves LENZ Therapeutics’ LNZ100 for presbyopia by August 31?

FDA approves LENZ Therapeutics’ LNZ100 for presbyopia by August 31?

$7k Vol.

$0 Liq.

12

Ended

Yes

FDA approvals in July

FDA approvals in July

$108k Vol.

$0 Liq.

12

Ended

TransCon hGH (sBLA)

FDA approves Unicycive’s Oxylanthanum Carbonate (OLC)?

FDA approves Unicycive’s Oxylanthanum Carbonate (OLC)?

$3k Vol.

$0 Liq.

32

Ended

No